MIAMI, FL--(Marketwire - September 08, 2009) -
| Highlighted Links |
Renato Corporation |
MacReport Media Publishing |
Mr. Morkunas further states, "Our second phase corporate growth development is to build generic biotech companies in developing countries using North American manufacturing standards." Vanguard Pharmaceutical Corporation is a natural integral part of Renato's strategic expansion program.
About Vanguard
Latin America is set to emerge as a globally significant market and its generics market is conservatively expected to reach US$6.4 billion by the year-end of 2009. Vanguard has been performing market price analysis of its drugs in several South American countries and has found their prices to be significantly lower than recent generic bid prices.
Vanguard is currently developing and evaluating subsidiary teams in Peru, Colombia, Brazil, and Paraguay who will bid on government tenders and distribute drugs in the private sector. Vanguard has recently travelled to both Peru and Colombia to set up teams in each country.
About Renato
Renato Corporation has decisively positioned itself to provide advanced diagnostic care via private clinics and health and wellness centers here in North America, and internationally.
Our professionally staffed clinics will be equipped with the latest non invasive diagnostic devices available to date. Renato Corporation will ensure that non-invasive diagnostic technologies such as Thermography and Electronic Beam Tomography (EBT) body scanning will be accessible to the general public.
At Renato Corporation, it is our pledge to continually seek out the latest innovative advanced medical diagnostic technologies available to continually provide the very best affordable private health care to our clients.
Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning
of the Private Securities Litigation Reform Act of 1995. Statements in this
release that are forward-looking statements are based on current
expectations and assumptions that are subject to known and unknown risks,
uncertainties, or other factors which may cause actual results,
performance, or achievements of the company to be materially different from
any future results, performance, or achievements expressed or implied by
such forward-looking statements. Actual results could differ materially
because of factors such as the effect of general economic and market
conditions, entry into markets with vigorous competition, market acceptance
of new products and services, continued acceptance of existing products and
services, technological shifts, and delays in product development and
related product release schedules, any of which may cause revenues and
income to fall short of anticipated levels. All information in this release
is as of the date of this release. The company undertakes no duty to update
any forward-looking statement to conform the statement to actual results or
changes in the company's expectations.
